Recent Articles
Friday’s Vital Data: Bristol-Myers Squibb, Intel and Activision Blizzard
By
Nicolas Chahine, InvestorPlace Contributor
Options trading was buzzing in Bristol-Myers, Activision Blizzard and Intel hursday. Here are the metrics that matter moving forward.
Cisco’s Earnings Sent the Stock Through the Roof – Will It Come Back to Earth?
By
Nicolas Chahine, InvestorPlace Contributor
Cisco stock has had a great recovery, and its latest round of earnings data is launching it higher. Is it too late to buy CSCO?
Tilray Stock Is Off Its Highs, But a Move is Imminent
By
Nicolas Chahine, InvestorPlace Contributor
Logic need not apply when trading Tilray stock. It is too quiet here and a big move is coming. The last time it was this tight, TLRY spiked big.
Thursday’s Vital Data: Eli Lilly, Twitter and Freeport-McMoRan
By
Nicolas Chahine, InvestorPlace Contributor
Options trading was abuzz in Eli Lilly, Twitter and Freeport-McMoRan on Wednesday. Here are the metrics and levels that matter here.
Akamai Stock Is a Wild Horse – Here’s How to Tame It
By
Nicolas Chahine, InvestorPlace Contributor
AKAM stock has been stuck in a descending channel for almost a year. This earnings report could be its ticket out it.
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.